Latest News & Features
Careers
With life sciences companies increasingly reliant on complex IP and licensing deals, the firm’s new hire is set to strengthen its technology transactions practice. 12 March 2026
Americas
In the deal worth up to $690 million for GSK, Italy-headquartered Alfasigma will acquire worldwide rights to linerixibat pending FDA approval. 11 March 2026
Careers
New counsel joins the firm from Kirkland & Ellis, bringing more than a decade of experience across advanced technology sectors. 10 March 2026
Americas
The telehealth platform’s shares jumped more than 40% after the news that it will sell Ozempic and Wegovy—and no longer faces a lawsuit from the Danish pharma giant. 10 March 2026
Big Pharma
UK government funding will support the London-based IP crime unit until 2029, as EUIPO and European authorities step up efforts to tackle unsafe counterfeits. 10 March 2026
Americas
Appeals court upholds lower court’s ruling, clarifying key legal questions concerning patent claims for blood‑testing devices. 9 March 2026
Americas
With IWD approaching, WIPR urges practitioners to submit nominations for its Influential Women in IP list, recognising outstanding female leaders across the profession. 6 March 2026
Americas
The healthcare company’s chief IP counsel is researching how law firms and patent attorneys are using AI tools to inform its own guidelines for external legal providers. 5 March 2026
Americas
Moderna settles, agreeing to part with up to $2.25 billion to avoid a trial and secure a licence to continue using the platform underpinning its COVID-19 vaccine. 5 March 2026
Careers
As the firm expands its IP offering, “an unusually versatile lawyer” with chemical, biologics, and medical device spaces expertise joins the New York office. 4 March 2026